Pfizer Inc (Pfizer) discovers, develops, manufactures and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, cancer, inflammation, immune disorders and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa and the Middle East. Pfizer is headquartered in New York, the US.

Headquarters United States of America

Address 235 E 42nd St, New York, 10017-5703


Telephone 1 212 5732323

No of Employees 79,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange PFE (NYSE)

Revenue (2021) $81.3B 95.2% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 140% (2021 vs 2020)

Market Cap* $276.2B

Net Profit Margin (2021) XXX 23.0% (2021 vs 2020)

* As of and is in US$

Access premium data and analytics for Pfizer Inc

6,000+

Clinical Trials

Determine Pfizer Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,600+

Catalyst Calendar

Proactively evaluate Pfizer Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,300+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Pfizer Inc’s relevant decision makers and contact details.

1,300+

Marketed Drugs

Understand Pfizer Inc’s commercialized product portfolio to stay one step ahead of the market.

1,000+

Pipeline Drugs

Identify which of Pfizer Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

970+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

130+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Pfizer Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

130+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

830+

Consumer Market Data Insights

Gain insights from product sales across markets, product categories and channels. Get intelligence on market shares, retail sales footprint, market position and strength for consumer segments and geographies.

580+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

90+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

30+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

7

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Pfizer Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Pfizer Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
Therapy Areas: Active Pharmaceutical Ingredients Celebrex
Internal Medicine Contract Manufacturing Eliquis
Oncology Enbrel
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Regulatory Approval In November, the company's bivalent booster vaccine was approved for Aust adults by the federal government.
2022 Contracts/Agreements In November, the company’s Institute of Translational Equitable Medicine (ITEM) and Fox Chase Cancer Center and Sylvester Comprehensive Cancer Center announced a collaboration to launch a cancer genomics study to characterize novel genetic, molecular, and social determinants of cancer across populations of African Ancestry.
2022 Regulatory Approval In November, the company and BioNTech secured approval from the UK Medicines and Healthcare products Regulatory Agency for Covid-19 booster vaccine.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Pfizer Inc Johnson & Johnson F. Hoffmann-La Roche Ltd AbbVie Inc Novartis AG
Headquarters United States of America United States of America Switzerland United States of America Switzerland
City New York New Brunswick Basel North Chicago Basel
State/Province New York New Jersey - Illinois -
No. of Employees 79,000 141,700 100,920 50,000 108,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Albert Bourla, Ph.D. Chairman; Chief Executive Officer Executive Board 2020 60
David M. Denton Executive Vice President; Chief Financial Officer Senior Management 2022 -
Rady A. Johnson Executive Vice President; Chief Compliance Officer; Chief Quality & Risk Officer Senior Management 2019 60
Mikael Dolsten, M.D., Ph.D. President - Worldwide Research and Development; Chief Scientific Officer Senior Management 2019 63
Christopher Stevo Senior Vice President; Chief Investor Relations Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?